valu usd unless otherwis note
view continu believ leadership chang unlock
valu share long-term howev patienc need near-
term manag focu continu remedi issu
north west campus regain confid surgeon
focus fill key product gap acceler top-line growth
manag exceed street revenu expect
guidanc sell-sid estim expect manag
revenu y/i exceed street expect
driven primarili pickup recon market growth
manag expect revenu guidanc fce
expect constant currenc revenu growth
y/i rbce due partli continu suppli constraint
softer recon market vs temporari reduct
uk elect procedur also one fewer bill
day compar prior year hit top-line growth fx
expect posit impact result rbce
separ manag anticip adjust cash ep
fce y/i assum tax rate
rang similar tax rate expect full year
sell-sid estim move lower manag
provid full guidanc anticip provid
qualit commentari specif new ceo said
compani previou target back full suppli product
still possibl risk timelin nonetheless
expect improv forecast sale growth rate
year progress driven normal bill day
increas suppli enhanc commerci execut new product
separ expect
toward lower end rang improv slightli subsequ
quarter north campu manufactur varianc anniversari
fx hedg loss moder oper expens move higher
anticip pay full bonus headwind
invest special sale rep acceler project
thesi unchang leadership chang unlock valu
share long-term patienc need lower
guidanc three time manag lower bar
believ larg expect investor
howev still recommend long-term investor
expect bryan hanson turn around compani howev patienc
need remedi issu complex still process
fix new manag reinvest busi drive
top-line growth new knee/should product launch ramp
price prior trade day market close estimate unless otherwis note
believ share outperform
peer group follow key reason
believ world-wide recon market larg stabl
given recent commentari orthoped manag
team well orthoped surgeon survey
believ world-wide recon market larg stabl
fact world-wide recon market growth remain
stabl y/i rang everi year
expect stabl world-wide recon trend continu
 job outlook overal economi continu
slowli improv price pressur remain constant
y/i rang includ mix
recent acquisit upcom new product launch
focus fill portfolio gap acceler top-line
growth addit ldrh expand zbh mi portfolio
add fastest-grow cervic disc market
share put compani within strike distanc
separ acquisit med-tech
sa provid robot play orthoped
market final note sever import
launch acceler
cementless knee persona revis system stemless
recent leadership chang unlock valu
share long-term patienc need manag
near-term focu continu remedi issu
north campu regain confid surgeon
custom focu vital project fill key
product gap acceler top-line growth expect
anoth peer group growth year
top bottom-lin await outcom
reinspect north campu could
occur year-end
bloomberg capit market estim upside/downside/target
base case scenario price target assum
compani grow top-line in-line market growth rate
medium term assum fda
issu warn letter north campu
base case scenario appli multipl peer
pro-forma adjust dilut cash ep estim
scenario model long-term adjust
cash ep growth slightli peer high-single-digit y/
rang analysi support outperform rate
upsid scenario assum return
top-line growth suppli concern resolv
compani regain surgeon confid launch new
product scenario also assum compani new ceo
bring addit experienc medic devic manag
help lead compani also explor potenti
divestitur sever under-perform busi includ
dental scenario long-term adjust dilut
ep growth could slightli larg cap md
downsid scenario assum compani
grow top-line well market growth rate
owe continu recon share loss on-going pressur
dental bone heal spine busi final call
pure price world-wide recon market take anoth
step scenario long-term adjust cash
ep growth would mid-single-digit y/i
deriv price target appli multipl pro-forma adjust
dilut cash ep estim large-cap med-tech peer
believ discount multipl appropri given lower top-lin growth rel
peer uncertainti regard on-going manufacturing/suppli issu price target
support outperform rate
risk rate price target
impedi achiev price target rate includ company-specif risk
suspens delay launch new product normal industri risk includ
competit depend agent distributor currenc intellectu properti
reimburs slow compani end market clinic trial risk regulatori
inc design develop manufactur market reconstruct
orthopaed implant includ small/larg joint dental spinal implant trauma
product sport medicin product relat orthopaed surgic product
sport extrem trauma
interest expens net
net incom attribut zmh
sport extrem trauma
